Valeur Intrinsèque du S&P et Nasdaq Contactez-nous
English English 中文(简) 中文(简) 中文(繁) 中文(繁) हिन्दी हिन्दी Español Español 日本語 日本語 한국어 한국어 Deutsch Deutsch Français Français
← Retour aux actions

St. Jude Medical, Inc. STJ NYSE

NYSE • Healthcare • Medical - Equipment & Services • USD

SharesGrow Score
65/100
3/6 Pass
SharesGrow Intrinsic Value
N/A
Negative cash flow

Il y a eu 50 transactions d'initiés récentes enregistrées pour St. Jude Medical, Inc. (STJ), dont 12 achats et 35 ventes. Le total des achats d'initiés s'élève à $1.32M et le total des ventes d'initiés à $112.49M.

Les initiés notables ayant une activité récente comprennent Starks Daniel J, Yarno Wendy L, Heinmiller John C. Les transactions d'initiés peuvent fournir des indications sur la façon dont la direction perçoit la valorisation et les perspectives futures de l'action.

Transactions d'Initiés — STJ

Date Nom Rôle Type de Transaction Actions Prix Moyen Valeur Actions détenues
2017-01-04 Starks Daniel J Director Restitution d'Actions 322,428 $69.08 $22.27M -
2017-01-04 Yarno Wendy L Director Restitution d'Actions 5,400 $38.51 $207.95K -
2017-01-04 Heinmiller John C Executive Vice President Restitution d'Actions 105,244 $69.08 $7.27M -
2017-01-04 Rousseau Michael T Director, President and CEO Restitution d'Actions 348,888 $61.62 $21.5M -
2017-01-04 Hill Barbara B Director Restitution d'Actions 5,400 $38.51 $207.95K -
2017-01-04 Dvorak David C Director Restitution d'Actions 5,599 $46.75 $261.75K -
2017-01-04 Fain Eric S Group President Restitution d'Actions 104,408 $61.62 $6.43M -
2017-01-04 Ebeling Philip VP, Chief Technology Officer Restitution d'Actions 34,376 $61.62 $2.12M -
2016-12-17 Starks Daniel J Chairman, CEO & President Exercice d'Options (Vente) 10,108 - - -
2016-12-17 Heinmiller John C Executive Vice President Exercice d'Options (Vente) 8,000 - - -
2016-12-17 Rousseau Michael T Chief Operating Officer Exercice d'Options (Vente) 8,000 - - -
2016-12-17 Fain Eric S Group President Exercice d'Options (Vente) 4,000 - - -
2016-12-17 Ebeling Philip VP, Chief Technology Officer Exercice d'Options (Vente) 704 - - -
2016-12-15 Rousseau Michael T Director, President and CEO Exercice d'Options (Vente) 50,000 $30.58 $1.53M -
2016-12-14 Fain Eric S Group President Exercice d'Options (Vente) 150,000 $30.58 $4.59M -
2016-12-12 Starks Daniel J Director Exercice d'Options (Vente) 500,000 $30.58 $15.29M -
2016-12-12 Fain Eric S Group President Don (Donné) 200 $80.20 $16.04K 80,092
2016-11-30 Heinmiller John C Executive Vice President Exercice d'Options (Vente) 250,000 $30.58 $7.65M -
2016-10-18 Rousseau Michael T Director, President and CEO Don (Donné) 300,000 $34.96 $10.49M -
2016-06-01 Yarno Wendy L Director Attribution de RSU 1,277 $78.27 $99.95K 30,240
2016-06-01 Hill Barbara B Director Attribution de RSU 1,277 $78.27 $99.95K 32,863
2016-06-01 Dvorak David C Director Attribution de RSU 1,277 $78.27 $99.95K 5,599
2016-05-04 Yarno Wendy L Director Attribution de RSU 2,401 $75.36 $180.94K 28,963
2016-05-04 Hill Barbara B Director Attribution de RSU 2,401 $75.36 $180.94K 31,586
2016-05-04 Dvorak David C Director Attribution de RSU 2,401 $75.36 $180.94K 4,322
2016-02-03 Hill Barbara B Director Exercice d'Options (Vente) 8,800 $40.93 $360.18K -
2016-01-02 Fain Eric S Officer Inconnu - - - -
2016-01-01 Ebeling Philip VP, Chief Technology Officer Cession - - - 1,397
2015-12-18 Heinmiller John C Executive Vice President Vente Informative 8,009 $61.16 $489.83K 237,211
2015-12-17 Ebeling Philip VP, Chief Technology Officer Cession 9,555 $69.08 $660.06K -
2015-12-17 Starks Daniel J Chairman, CEO & President Exercice d'Options (Vente) 10,108 - - 10,108
2015-12-17 Heinmiller John C Executive Vice President Exercice d'Options (Vente) 8,000 - - 8,000
2015-12-17 Rousseau Michael T Chief Operating Officer Exercice d'Options (Vente) 8,000 - - 8,000
2015-12-17 Fain Eric S Group President Exercice d'Options (Vente) 4,000 - - 4,000
2015-12-17 Becker Joel President, Americas Exercice d'Options (Vente) 2,164 - - -
2015-12-07 Rousseau Michael T Chief Operating Officer Attribution de RSU 37,052 - - 37,052
2015-12-07 Fain Eric S Group President Attribution de RSU 11,088 - - 11,088
2015-12-07 Becker Joel President, Americas Attribution de RSU 6,488 - - 6,488
2015-10-31 Becker Joel President - Usd Exercice d'Options (Vente) 875 - - -
2015-10-28 Starks Daniel J Chairman, CEO & President Exercice d'Options (Vente) 120,000 $40.55 $4.87M -
2015-08-04 Dvorak David C Director Cession - - - -
2015-08-04 Dvorak David C Director Attribution de RSU 1,921 $72.76 $139.77K 1,921
2015-07-29 Starks Daniel J Chairman, CEO & President Exercice d'Options (Vente) 100,000 $40.55 $4.06M 120,000
2015-05-07 Yarno Wendy L Director Attribution de RSU 2,382 $71.35 $169.96K 26,562
2015-05-07 Hill Barbara B Director Attribution de RSU 2,382 $71.35 $169.96K 20,385
2015-05-01 Hill Barbara B Director Exercice d'Options (Vente) 3,229 $40.40 $130.45K -
2015-04-28 Starks Daniel J Chairman, CEO & President Exercice d'Options (Vente) 100,000 $40.55 $4.06M 220,000
2015-04-24 Heinmiller John C Executive Vice President Exercice d'Options (Vente) 160,000 $40.55 $6.49M -
2015-04-24 Fain Eric S Group President Exercice d'Options (Vente) 47,000 $40.55 $1.91M -
2015-04-24 Becker Joel President, Americas Exercice d'Options (Vente) 2,998 $52.98 $158.83K -
■ Informatif — transaction sur marché ouvert (la plus significative) ■ Non informatif (achat) — récompense, exercice d'option, conversion ■ Non informatif (vente) — retenue fiscale, vente à l'acquisition ■ Neutre — don, fiducie, expiration

Les autres consultent aussi

LLY
LLY
Eli Lilly and Company
$922.50
-0.76%
 JNJ
JNJ
Johnson & Johnson
$240.10
+0.90%
 ABBV
ABBV
AbbVie Inc.
$210.32
+1.86%
 RHHBF
RHHBF
Roche Holding AG
$418.50
+1.82%
 RHHBY
RHHBY
Roche Holding AG
$51.02
+0.65%
 AZN
AZN
AstraZeneca PLC
$204.38
+1.06%
 NVSEF
NVSEF
Novartis AG
$156.48
+0.00%
 MRK
MRK
Merck & Co., Inc.
$119.96
-0.16%
Contactez-nous
🎓
SharesGrow Académie
Apprenez à calculer la Valeur Intrinsèque et trouver des actions sous-évaluées.
Sessions hebdomadaires en direct
📧 [email protected]
📞 +65 8912 8000
Envoyez-nous un message